Cancer Family
Sarcoma
CI-CAN-00000344SARExplore in graph →
634 active trials17 approved drugs182 evidence items
- NCIt
- C9118
- OncoTree
- SARCNOS
- DOID
- 1115
- MeSH
- D012509
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000344SARExplore in graph →
Clinical trials
2,687 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (365)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04757337 | Comparison of Oral Cyclophosphamide vs Doxorubicin in ≥65 Years Old Advanced or Metastatic Soft Tissue Sarcoma Patients(GERICO14) | unknown | Phase 3 | 214 | UNICANCEROTHER | 1 | Mar 25, 2025 | clinicaltrials |
| NCT06565858 | Physical Activity and Sarcoma, Role and Impact on Outcome | unknown | — | 750 | European Institute of OncologyOTHER | 1 | Sep 20, 2024 | clinicaltrials |
| NCT06593899 | The Total Neoadjuvant Therapy for Soft Tissue Sarcoma of the Extremities | unknown | Phase 2 | 51 | Fujian Medical University Union HospitalOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT03375437 | RNASARC - Molecular Screening Program of Soft Tissue Sarcomas With Complex Genomic Profile to Detect NTRK1/2/3, ROS1 or ALK Gene Fusions.(RNASARC) | unknown | N/A | 376 | Centre Leon BerardOTHER | 1 | Aug 26, 2024 | clinicaltrials |
| NCT04535713 | GALLANT: Metronomic Gemcitabine, Doxorubicin, Docetaxel and Nivolumab for Advanced Sarcoma | unknown | Phase 2 | 260 | Sarcoma Oncology Research Center, LLCOTHER | 1 | Jul 5, 2024 | clinicaltrials |
| NCT05607602 | Are Uterine Fibroids Pro-thrombotic? | unknown | — | 105 | King's College Hospital NHS TrustOTHER | 1 | Jun 11, 2024 | clinicaltrials |
| NCT02910895 | A Platform of Patient Derived Xenografts (PDX) and 2D/3D Cell Cultures of Soft Tissue Sarcomas (STS)(SarcomaPDX) | unknown | N/A | 40 | The Netherlands Cancer InstituteOTHER | 1 | Jun 7, 2024 | clinicaltrials |
| NCT05955105 | A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies | unknown | Phase 1 / Phase 2 | 200 | Innolake BiopharmINDUSTRY | 1 | May 21, 2024 | clinicaltrials |
| NCT04480502 | ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma(ENVASARC) | unknown | Phase 2 | 207 | Tracon Pharmaceuticals Inc.INDUSTRY | 2 | May 17, 2024 | clinicaltrials |
| NCT05396118 | Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients | unknown | Phase 2 | 15 | Rigshospitalet, DenmarkOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT05942456 | Soluble B7-H3 as a Biomarker for Osteosarcoma | unknown | — | 200 | Peking University People's HospitalOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT06412458 | IM83 Clinical Study of CAR-T Cell Therapy in Patients With Relapsed or Refractory Osteosarcoma | unknown | Phase 1 | 9 | Beijing Immunochina Medical Science & Technology Co., Ltd.INDUSTRY | 1 | May 14, 2024 | clinicaltrials |
| NCT05081141 | HHV8 and Solid Organ Transplantation | unknown | — | 250 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoOTHER | 1 | May 7, 2024 | clinicaltrials |
| NCT03993106 | A Study of sEphB4-HSA in Kaposi Sarcoma | unknown | Phase 2 | 65 | Vasgene Therapeutics, IncINDUSTRY | 1 | May 2, 2024 | clinicaltrials |
| NCT06384248 | Phase II Clinical Study of LTC004 in Patients With Advanced Sarcoma | unknown | Phase 1 / Phase 2 | 30 | LetolabINDUSTRY | 0 | Apr 25, 2024 | clinicaltrials |
| NCT05926492 | A Clinical Study of Surufatinib Combined With Chemotherapy as Neoadjuvant Treatment in Osteosarcoma | unknown | Phase 2 | 160 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Apr 17, 2024 | clinicaltrials |
| NCT06363201 | Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours | unknown | N/A | 40 | Catalysis SLINDUSTRY | 1 | Apr 12, 2024 | clinicaltrials |
| NCT04032964 | Dose Finding Study of L19TNF and Doxorubicin in Patients With STS(DOXO75) | unknown | Phase 1 | 2 | Philogen S.p.A.INDUSTRY | 1 | Apr 8, 2024 | clinicaltrials |
| NCT04650984 | A Study Comparing the Efficacy of L19TNF+Doxorubicin vs Doxorubicin Alone as First-line Therapy in Patients With Advanced or Metastatic Soft Tissue Sarcoma(FIBROSARC) | unknown | Phase 3 | 102 | Philogen S.p.A.INDUSTRY | 5 | Apr 8, 2024 | clinicaltrials |
| NCT05057130 | Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors | unknown | Phase 2 / Phase 3 | 50 | Blokhin's Russian Cancer Research CenterOTHER | 1 | Apr 1, 2024 | clinicaltrials |
| NCT05057143 | 3D Printed Implants for the Defect Reconstruction in Patients With Chest Wall Tumors | unknown | N/A | 30 | Blokhin's Russian Cancer Research CenterOTHER | 1 | Apr 1, 2024 | clinicaltrials |
| NCT05057195 | Wide Excision of Soft Tissue Sarcomas in Combination With Interstitial Radiation Therapy | unknown | N/A | 78 | Blokhin's Russian Cancer Research CenterOTHER | 1 | Apr 1, 2024 | clinicaltrials |
| NCT06291662 | Evaluation of Performance Characteristics and Applicability in Oncology of Devices Customized Medical Devices Made by 3D Printing | unknown | N/A | 12 | Kathleen McGreevyOTHER | 1 | Mar 4, 2024 | clinicaltrials |
| NCT06282237 | Clinical Evaluation, Motor Performance and Quality of Life in Patients Affected by Soft Tissue Sarcomas, Undergoing Surgical Treatment: Observational Study(1206) | unknown | — | 13 | Fondazione Policlinico Universitario Campus Bio-MedicoOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT03462888 | Clinico-biological Study/Characterization of Rhabdomyosarcoma in Adolescents and Young Adults, 15-25-year-old Patients(RMS-AJA-1701) | unknown | — | 113 | Centre Oscar LambretOTHER | 1 | Feb 9, 2024 | clinicaltrials |
| NCT04149691 | Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies | unknown | Phase 1 | 42 | Celon Pharma SAINDUSTRY | 1 | Feb 7, 2024 | clinicaltrials |
| NCT05189483 | Albumin-bound Paclitaxel Plus Camrelizumab for Advanced Soft Tissue Sarcoma. | unknown | Phase 2 | 40 | Henan Cancer HospitalOTHER_GOV | 1 | Feb 7, 2024 | clinicaltrials |
| NCT05453409 | Study on Clinical Features, Treatment Mode and Survival of Sarcoma | unknown | — | 6,000 | Henan Cancer HospitalOTHER_GOV | 1 | Feb 7, 2024 | clinicaltrials |
| NCT05615545 | Cryoablation for Advanced Bone and Soft Tissue Tumors | unknown | — | 30 | Henan Cancer HospitalOTHER_GOV | 1 | Feb 7, 2024 | clinicaltrials |
| NCT05718778 | Piamprilizumab (AK105) Combined With Radiotherapy for Neoadjuvant Treatment of Soft Tissue Sarcoma | unknown | N/A | 31 | Henan Cancer HospitalOTHER_GOV | 1 | Feb 7, 2024 | clinicaltrials |
| NCT06234670 | Risk Factors and A Prediction Model of Recurrence of Uterine Fibroids | unknown | — | 3,200 | Wenwen WangOTHER | 1 | Jan 31, 2024 | clinicaltrials |
| NCT03242382 | Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression.(PalboSarc) | unknown | Phase 2 | 40 | Grupo Espanol de Investigacion en SarcomasOTHER | 1 | Jan 23, 2024 | clinicaltrials |
| NCT04595994 | Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma and Osteosarcoma(SeliSarc) | unknown | Phase 1 | 14 | Grupo Espanol de Investigacion en SarcomasOTHER | 1 | Jan 23, 2024 | clinicaltrials |
| NCT06217003 | Trilaciclib Combined With Chemotherapy for Perioperative Treatment of Osteosarcoma | unknown | Phase 2 | 20 | The First Affiliated Hospital of Xinxiang Medical CollegeOTHER | 1 | Jan 22, 2024 | clinicaltrials |
| NCT04589754 | Adriamycin and Ifosfamide Combined With Sintilimab | unknown | Phase 2 | 176 | Sun Yat-sen UniversityOTHER | 1 | Jan 2, 2024 | clinicaltrials |
| NCT04927260 | French Long Term Registry With Longitudinal Follow up of PDGFRA D842V-GIST Patients(AVIATOR2020) | unknown | — | 25 | Centre Leon BerardOTHER | 1 | Dec 26, 2023 | clinicaltrials |
| NCT06165718 | Study for the Clinical Roadmap and Prognosis of Pulmonary Artery Sarcoma. | unknown | — | 120 | China-Japan Friendship HospitalOTHER | 1 | Dec 15, 2023 | clinicaltrials |
| NCT06171282 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors | unknown | Early Phase 1 | 9 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | Dec 14, 2023 | clinicaltrials |
| NCT03134742 | Radiation Effects on Bone | unknown | — | 50 | State University of New York - Upstate Medical UniversityOTHER | 1 | Nov 21, 2023 | clinicaltrials |
| NCT03600649 | Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas | unknown | Phase 1 | 50 | Salarius Pharmaceuticals, LLCINDUSTRY | 1 | Nov 21, 2023 | clinicaltrials |
| NCT06125171 | Tucidinostat Plus Apatinib for Advanced Osteosarcoma | unknown | Phase 2 | 46 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 0 | Nov 9, 2023 | clinicaltrials |
| NCT06117878 | Safety and Efficacy of NK510 to Treat Osteosarcoma and Soft Tissue Sarcoma | unknown | Early Phase 1 | 12 | Base Therapeutics (Shanghai) Co., Ltd.INDUSTRY | 1 | Nov 7, 2023 | clinicaltrials |
| NCT05094804 | A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents | unknown | Phase 1 / Phase 2 | 172 | OncoResponse, Inc.INDUSTRY | 1 | Nov 2, 2023 | clinicaltrials |
| NCT06114173 | Efficacy and Safety Study of Cardunilizumab in Soft Tissue Sarcoma | unknown | Early Phase 1 | 15 | Xiangya Hospital of Central South UniversityOTHER | 1 | Nov 2, 2023 | clinicaltrials |
| NCT03742193 | Pulmonary Resectable Metastases of Osteosarcoma With Anti-angiogenics and CHemotherapy(PROACH) | unknown | Phase 2 | 43 | Ruijin HospitalOTHER | 1 | Nov 1, 2023 | clinicaltrials |
| NCT06110650 | A Study of Surufatinib in the Treatment of Advanced Soft Tissue Sarcoma | unknown | N/A | 29 | Fudan UniversityOTHER | 0 | Oct 31, 2023 | clinicaltrials |
| NCT04893356 | Impact of O6-methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and MGMT Expression on Dacarbazine Treated Sarcoma Patients (MGMT)(MGMT) | unknown | — | 75 | National Cancer Institute, NaplesOTHER | 1 | Oct 30, 2023 | clinicaltrials |
| NCT05684874 | Multiparametric Quantitative MRI and Response to Neoadjuvant Radiotherapy for Soft-tissue Sarcoma(SarQuantIRM) | unknown | N/A | 25 | Centre Leon BerardOTHER | 1 | Oct 30, 2023 | clinicaltrials |
| NCT04074564 | MASCT-I Combined With Apatinib and/or Camrelizumab in the Treatment of Bone and Soft Tissue Sarcoma | unknown | Early Phase 1 | 60 | HRYZ Biotech Co.INDUSTRY | 1 | Oct 23, 2023 | clinicaltrials |
| NCT03792867 | Radical Resection and HIPEC for Recurrent Retroperitoneal Sarcoma | unknown | N/A | 5 | National Cancer Centre, SingaporeOTHER | 1 | Oct 11, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Mar 25, 2025source: clinicaltrials